UCI Institute for Clinical & Translational Science

UNIVERSITY OF CALIFORNIA-IRVINE

At a Glance

1

Educational Resources Posted

2

Consortium News Stories Posted

0

Events Posted

2

Opportunities Posted

642

Publications citing CTSA Program Grant

17

Users from Hub Registered
Website
Contact PI Organization
Programs

UL1 Award

KL2 Award

TL1 Award

Funded Years
2012 - 2021

Consortium News

Celebrating ten years of shared infrastructure and programs that accelerate research and improve health, UC BRAID convened its annual meeting on October 14-15, 2019 at the UCLA Luskin Conference Center. UC BRAID, the University of California Biomedical Research Acceleration, Integration, & Development, is a consortium of the five UC academic medical centers—Davis, Irvine, Los Angeles, San Diego
What is CEREC? CEREC was established in 2016 to provide an outlet for obtaining external reviews for CTSA-funded pilot research and to minimize the likelihood of bias and conflicts of interest. CEREC also offers a larger pool of expertise from which to draw precisely matched reviews for scientific lines of inquiry that may not be well represented within the institution receiving the proposal. This

Educational Content

University Of California Irvine

The Healthcare Analytics specialized studies program is ideal for professionals who want to pursue or advance their career. The program is designed for both healthcare and information technology professionals looking to learn research and analytical skills to collect, organize, and visualize data in order to change the healthcare landscape. Using data analytics in a healthcare setting can improve

Opportunities

Position Summary: The Institute for Clinical and Translational Science is a special project department housed under the Office of Research on the UCI Campus. The UCI CTSA is one of 62 NIH-NCATS funded institutes in the US. The ICTS Mission is to improve health and healthcare by catalyzing translational research across the spectrum and by advancing the science of translation. The cohesive theme of

The University of California, Irvine (UCI), in partnership with the Grant Cooper Group, announces a national search for the Director of the UCI Institute for Clinical and Translational Science (ICTS). UCI is ranked 8th best public university in the nation and 35th among all American universities – public and private, according to the annual U.S. News & World Report "America's Best Colleges" 2020

Poster Sessions

UCI Optional Functions (2019-2024): 1) Robots that Run with Humans; 2) Harnessing School Based Physical Fitness Data
University Of California Irvine

The field of robotic rehabilitation technology (RRT) is at a crossroads. People in need of rehabilitation therapies suffer from an enormous range of conditions, including spinal cord injury, stroke, muscle degenerative diseases, and early-life neuromotor injury. RRT holds the promise of effective and accessible therapies in ways previously unimaginable. The gaps between the technology advances and

Publications

Newer bronchopulmonary dysplasia definitions and prediction of health economics impacts in very preterm infants

To compare the abilities of bronchopulmonary dysplasia (BPD) definitions to predict hospital charges as a surrogate of disease complexity. Retrospective study of infants admitted to the neonatal intensive care unit (NICU) less than 32 weeks gestational age. Subjects were classified according to the

Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice

Recent data have shown that single-fraction irradiation delivered to the whole brain in less than tenths of a second using FLASH radiotherapy (FLASH-RT), does not elicit neurocognitive deficits in mice. This observation has important clinical implications for the management of invasive and treatment

Recruitment and retention of participant and study partner dyads in two multinational Alzheimer's disease registration trials

Early study exit is detrimental to statistical power and increases the risk for bias in Alzheimer's disease clinical trials. Previous analyses in early phase academic trials demonstrated associations between rates of trial incompletion and participants' study partner type, with participants